254063 What If? Predicting the Impact of Modeling and Simulation in our Future Healthcare

Tuesday, November 1, 2011: 2:30 PM

Dennis Gillings, CBE, PhD , Chair & CEO, Quintiles, Durham, NC
Modeling and simulation is poised to transform drug development across the whole lifecycle from discovery to commercialization, as well as to inform future healthcare planning and practice. This transformation will translate into more targeted treatments coupled with evidence-based decision-making, supporting improvements in health and healthcare. Dr. Gillings will discuss the position of the biostatistician as a facilitator of multi-disciplinary teams helping them to understand the causes of disease and the impact of new therapies while using ever-larger data sets to turn data into intelligence. The biostatisticians of the future will need to master new modeling and simulation techniques to push the frontiers of healthcare.

Learning Areas:
Biostatistics, economics

Learning Objectives:
Discuss how to master new modeling and simulation techniques to push the frontiers of healthcare.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Chair and CEO of Quintiles.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.